Literature DB >> 11246585

The risk of cataract among users of inhaled steroids.

S S Jick1, C Vasilakis-Scaramozza, W C Maier.   

Abstract

Prolonged exposure to inhaled corticosteroids among adults over 49 years old has been reported to increase cataract risk. Small-scale studies of inhaled steroid users suggest that no increased risk for children and young adults exists. To describe cataract risk among people with asthma who use inhaled corticosteroids relative to patients with asthma with no history of corticosteroid use, we conducted a retrospective observational cohort study of patients identified from the United Kingdom-based General Practice Database with a nested case-control analysis. Relative to patients who do not use corticosteroids, all inhaled corticosteroid users were at a marginally increased risk of cataract (RR = 1.3). Among individuals 40 years of age or older, the risk ratio increased with use of increasing numbers of inhaled corticosteroid prescriptions after controlling for diabetes mellitus, hypertension, and smoking history. This trend was not evident in those under age 40.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11246585     DOI: 10.1097/00001648-200103000-00016

Source DB:  PubMed          Journal:  Epidemiology        ISSN: 1044-3983            Impact factor:   4.822


  17 in total

1.  A population based case-control study of cataract and inhaled corticosteroids.

Authors:  L Smeeth; M Boulis; R Hubbard; A E Fletcher
Journal:  Br J Ophthalmol       Date:  2003-10       Impact factor: 4.638

Review 2.  Corticosteroid-associated tendinopathies: an analysis of the published literature and spontaneous pharmacovigilance data.

Authors:  Irene Blanco; Stephan Krähenbühl; Raymond G Schlienger
Journal:  Drug Saf       Date:  2005       Impact factor: 5.606

Review 3.  Efficacy and safety of inhaled corticosteroids in patients with COPD: a systematic review and meta-analysis of health outcomes.

Authors:  Gerald Gartlehner; Richard A Hansen; Shannon S Carson; Kathleen N Lohr
Journal:  Ann Fam Med       Date:  2006 May-Jun       Impact factor: 5.166

Review 4.  Benefits and risks of inhaled corticosteroids in chronic obstructive pulmonary disease.

Authors:  Marcel Bonay; Catherine Bancal; Bruno Crestani
Journal:  Drug Saf       Date:  2002       Impact factor: 5.606

Review 5.  Ocular toxicity of systemic asthma and allergy treatments.

Authors:  Leonard Bielory
Journal:  Curr Allergy Asthma Rep       Date:  2006-07       Impact factor: 4.806

6.  Characteristics Associated With Receiving Cataract Surgery in the US Medicare and Veterans Health Administration Populations.

Authors:  Annie M Wu; Connie M Wu; Victoria L Tseng; Paul B Greenberg; JoAnn A Giaconi; Fei Yu; Flora Lum; Anne L Coleman
Journal:  JAMA Ophthalmol       Date:  2018-07-01       Impact factor: 7.389

7.  Pharmacogenomic test that predicts response to inhaled corticosteroids in adults with asthma likely to be cost-saving.

Authors:  Ann Chen Wu; Charlene Gay; Melisa D Rett; Natasha Stout; Scott T Weiss; Anne L Fuhlbrigge
Journal:  Pharmacogenomics       Date:  2015-04-16       Impact factor: 2.533

Review 8.  Inhaled corticosteroids in chronic obstructive pulmonary disease: a pro-con perspective.

Authors:  K Suresh Babu; Jack A Kastelik; Jaymin B Morjaria
Journal:  Br J Clin Pharmacol       Date:  2014-08       Impact factor: 4.335

9.  Risk of adverse gastrointestinal events from inhaled corticosteroids.

Authors:  Richard A Hansen; Wanzhu Tu; Jane Wang; Roberta Ambuehl; Clement J McDonald; Michael D Murray
Journal:  Pharmacotherapy       Date:  2008-11       Impact factor: 4.705

Review 10.  Falls in patients with chronic obstructive pulmonary disease: a call for further research.

Authors:  Marc Roig; Janice J Eng; Jeremy D Road; W Darlene Reid
Journal:  Respir Med       Date:  2009-05-05       Impact factor: 3.415

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.